Xenios AG
The company develops and manufactures extracorporeal life support (ECLS) technologies for patients with cardiac and pulmonary failure. Its primary product is the Xenios console, a multifunctional platform that combines heart and lung support to facilitate gas exchange and cardiovascular assistance. As a subsidiary of Fresenius Medical Care, the firm provides medical devices including oxygenators, pump drives, and patient kits for adult and pediatric ECMO treatments in intensive care settings.
Healthtech
Medical Devices
Healthcare
Funding summary
- Total raised
- €0
- Funding rounds
- 1
Investors in Xenios AG
Investors on record for Xenios AG. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Xenios AG?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors